MedPath

Chlorhexidine Disk for Prevention of Exit-site Infection in Peritoneal Dialysis Patients

Not Applicable
Completed
Conditions
Peritoneal Dialysis Catheter Exit Site Infection
Interventions
Device: Chlorhexidine-impregnated disk
Registration Number
NCT03406520
Lead Sponsor
Singapore General Hospital
Brief Summary

The purpose of the study is to evaluate the efficacy and safety of chlorhexidine-impregnated disk in preventing catheter exit-site infection in peritoneal dialysis patients

Detailed Description

The primary aim of the study is to examine the exit-site infection rate in patients using chlorhexidine-impregnated dressing.

The participant will be followed up at 2, 6, 12, 24, 36 and 52 weeks of study and during each visit the catheter exit-site will be examined by one of the investigators for any sign of infection or allergic reaction, and questionnaires about satisfaction with use of study material (biopatch) will be asked by a study team member at the 12 week visit of the study. Each participant will be followed up for one year.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria
  • All adult incident peritoneal dialysis patients between 21 to 90 years old, who are followed up in Singapore General Hospital
Exclusion Criteria
  1. patients who have known history of allergy to chlorhexidine
  2. patients who had previous history of peritoneal dialysis catheter exit-site infection
  3. patients with mentally challenging conditions who are unable to give the valid consent for the study
  4. patients who have been involved in another study for exit site infection

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Chlorhexidine-impregnated diskChlorhexidine-impregnated diskThe chlorhexidine-impregnated disk, will be applied to the peritoneal dialysis catheter exit-site and the disk will be changed once a week
Primary Outcome Measures
NameTimeMethod
Exit-site/tunnel infection rateone year

Exit-site/tunnel infection rate (reported as episodes per patient-year) in patients receiving chlorhexidine-impregnated disk

Secondary Outcome Measures
NameTimeMethod
Time to the first episode of exit-site/tunnel infectionone year

days from peritoneal dialysis initiation to the time develops first exit-site/tunnel infection

time to first episode of peritonitisone year

days from peritoneal dialysis initiation to the time develops first episode of peritonitis

Peritoneal dialysis infection-related hospitalizationone year

Hospitalization due to peritoneal dialysis-related infection

comparison of the above outcomes with historical cohort using topical antibiotics creamone year

comparison of exit-site/tunnel infection rate, peritonitis rate, time to first episode of exit-site/tunnel infection or peritonitis, technique failure rate, hospitalization rate, adverse events, mortality with historical cohort patients using topical gentamicin cream

adverse eventsone year

any local or systemic adverse events

mortalityone year

all-cause mortality

patient satisfaction with the use of chlorhexidine-impregnated sponge dressingthird month of study

Questionnaires related to the treatment with chlorhexidine-impregnated disk

peritonitis rateone year

Peritonitis rate (reported as episodes per patient-year) in patients receiving chlorhexidine-impregnated disk

technique failure rateone year

technique failure is defined as transfer to hemodialysis for \>= 30 days

Trial Locations

Locations (1)

Singapore General Hospital

🇸🇬

Singapore, Singapore

© Copyright 2025. All Rights Reserved by MedPath